Rabbit Sequestosome Signaling Sampler Kit Monoclonal Antibody

Rabbit Sequestosome Signaling Sampler Kit Monoclonal Antibody

Cat. No.: DAB-0012822

Size: 20 µL Size: 100 µL Size: Customer Size
Product Information
Clonality Monoclonal
Host Species Rabbit
Product Description Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly162 of human SQSTM1/p62 protein, residues near the amino terminus of human TRAF6 protein, residues surrounding the Lys63 branch of the human diubiquitin chain, residues surrounding Arg220 of human TrkA, residues surrounding Ala275 of human NRF2 protein, and residues near the carboxy terminus of human KEAP1 protein.
Format Liquid
Purity Affinity purity
Target Information
Gene Description Sequestosome 1 is a ubiquitin binding protein involved in cell signaling, oxidative stress, and autophagy. It was first identified as a protein that binds to the SH2 domain of p56Lck and independently found to interact with PKCζ. SQSTM1 was subsequently found to interact with ubiquitin, providing a scaffold for several signaling proteins and triggering degradation of proteins through the proteasome or lysosome. Interaction between SQSTM1 and TRAF6 leads to the K63-linked polyubiquitination of TRAF6 and subsequent activation of the NF-κB pathway. Protein aggregates formed by SQSTM1 can be degraded by the autophagosome. SQSTM1 binds autophagosomal membrane protein LC3/Atg8, bringing SQSTM1-containing protein aggregates to the autophagosome. Lysosomal degradation of autophagosomes leads to a decrease in SQSTM1 levels during autophagy; conversely, autophagy inhibitors stabilize SQSTM1 levels. SQSTM1 also interacts with KEAP1, which is a cytoplasmic inhibitor of NRF2, a key transcription factor involved in cellular responses to oxidative stress., der basal conditions, KEAP1 binds and retains NRF2 in the cytoplasm where it can be targeted for ubiquitin-mediated degradation. Small amounts of constitutive nuclear NRF2 maintain cellular homeostasis through regulation of basal expression of antioxidant response genes. Following oxidative or electrophilic stress, KEAP1 releases NRF2, thereby allowing the activator to translocate to the nucleus and bind to ARE-containing genes. The coordinated action of NRF2 and other transcription factors mediates the response to oxidative stress. Thus, accumulation of SQSTM1 can lead to an increase in NRF2 activity. KEAP1 also targets the down regulation of NF-κB activity by targeting IKKβ degradation. TrkA is a member of Trk receptor tyrosine kinases and is activated by NGF, which stimulates TrkA polyubiquitination. TrkA regulates proliferation and is important for development and maturation of the nervous system. SQSTM1 interaction with TRAF6 controls synthesis of K63 polyubiquititination on TrkA. TrkA polyubiquitination is essential for neurotrophin-dependent receptor internalization, cell differentiation, and signaling.
Shipping & Storage
Shipping Shipped at 4 °C.
Storage Instructions Store at +4 °C short term (1-2 weeks). Store at -20 °C long term.
Storage Buffer Constituent: 100% PBS
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top